In a groundbreaking revelation, the All India Institute of Medical Sciences (AIIMS) in Bhopal has pioneered an Ayurvedic treatment for breast cancer, utilizing bioactive compounds extracted from Moringa leaves and pods. Termed the "Core Drug," this innovative solution is a collaborative effort with the Indian Institute of Science Education and Research (IISER) in Bhopal.
The Core Drug, derived from Moringa, has shown promising results in combating various cancer types, with a particular focus on breast cancer. Initial laboratory development involved testing on 1,000 artificial breast cells, revealing the drug's ability to impede the formation of new breast cancer cells.
Notably, the Core Drug exhibited no adverse effects on rats during the experimental phase. Rats with breast cancer were administered the Core Drug for a continuous 15-day period, resulting in a gradual destruction of breast cancer cells. The positive outcome has paved the way for further exploration of this Ayurvedic approach in human trials.
Moringa is often called the drumstick tree
Moringa or Munga in Hindi is a plant that is often called the drumstick tree, the miracle tree. Moringa has been used for centuries due to its medicinal properties and health benefits. It also has antifungal, antiviral, antidepressant, and anti-inflammatory properties.
Safe for Test Subjects
Research conducted at AIIMS involved administering the Core Drug to different groups of rats, including those with breast cancer and a control group. Significantly, the drug demonstrated no side effects on the normal group of rats, indicating its safety in non-cancerous cells.
Potent Antioxidant Properties
Dr. Sukesh Mukherjee from AIIMS's Biochemistry Department said that the future administration of this drug to humans would likely take the form of tablets. Moreover, the antioxidant-rich nature of Moringa, specifically its drumstick leaf water, offers a potential alternative to chemotherapy by aiding in the elimination of free radicals and harmful toxins.
Tablet Form for Human Use
Dr. Mukherjee emphasized that when the Core Drug is eventually used in human trials, it will be available in tablet form, providing a convenient and accessible treatment option. The potential to treat breast cancer without resorting to chemotherapy adds another layer of significance to this discovery.
Sharing Insights at Expocon-2024
Researchers and experts are set to share their findings and experiences at the Central Zone Expocon-2024 organized by the Association of Clinical Biochemists of India (ACBI) at AIIMS on January 19th and 20th. The Atal Bihari Vajpayee Auditorium will host discussions on ongoing research related to cancer-related diseases, providing a platform for collaboration and knowledge exchange.
No comments:
Post a Comment